arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Absci Corporation

ABSI Health Care Biotechnology: Commercial Physical & Biological Resarch
$9.37
▲ +3.3% Today
as of Oct 22, 16:45 ET
Last 30 days +15.82% Sep 14 → Oct 22
$7.65 $8.69 $9.73 $10.78 $11.82 Sep 14 Sep 22 Sep 29 Oct 07 Oct 14 Oct 22
Open
$9.69
High
$9.95
Low
$8.93
Volume
$4M
Avg Vol
$4M
Mkt Cap
$1.8B
P/E (TTM)
—
Beta
—
52w High
$12.05
52w Low
$2.24
Div Yield
—
Shares Out
—

Recent Press Releases & News last 60 days · 8 items

Oct 16 · 23:11 Simply Wall St.
Absci (ABSI) Stock Seems Rich Against Its Book Value Backdrop
Oct 13 · 12:00 PR GlobeNewswire
Absci to Report Business Updates and Third Quarter 2026 Financial and Operating Results on November 12, 2026
Oct 7 · 23:17 Simply Wall St.
Absci (ABSI) Stock Dropped, So What Is Behind The Latest Attention?
▸ Show all 8 press releases & news Free account →

ABSI earnings at a glance

The options market is pricing a move of about ±10.8% after the report, a range of roughly $8.36 to $10.38 from today's $9.37. Over its last 2 reports the stock rose the next day 1 time and fell 1, moving ±2.2% on average; after the most recent report on May 7, 2026 it moved -3.4%. That means options currently expect more movement than ABSI has typically delivered. ABSI beat the consensus EPS estimate in 2 of its last 4 reported quarters. Implied volatility is currently 98%. The share price of $9.37 sits in the middle of its 52-week range.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$2.24
$12
73% of range
Avg surprise (last 4)
-4.5%
Avg reaction (last 2)
-1.2%
50% positive
Latest IV / EM
98%
EM ±10.8% · $9 · Oct 16

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.45$-0.39$-0.32$-0.26$-0.19 Actual $-0.26Actual $-0.45Actual $-0.24Actual $-0.22Actual $-0.22Actual $-0.24Actual $-0.21Est $-0.23Actual $-0.24Est $-0.19Actual $-0.20Est $-0.19Actual $-0.19Est $-0.20Actual $-0.21 MarJunSepMarJunSepMar/2025Jun/2025Sep/2025Mar/2026Jun
Revenue vs Net Income Revenue Net income
$-33M$-24M$-16M$-7M$2M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $-0.21 — — — — financials
Thu May 7, 2026Mar/2026 $-0.19 $-0.20 +5.0% +9.5% -3.4% earnings
Wed Nov 12, 2025Sep/2025 $-0.20 $-0.19 -5.3% — — earnings
Tue Aug 12, 2025Jun/2025 $-0.24 $-0.19 -26.3% — — earnings
Tue May 13, 2025Mar/2025 $-0.21 $-0.23 +8.7% — +1.0% earnings
Mon Sep 30, 2024Sep 2024 $-0.24 — — — — financials
Sun Jun 30, 2024Jun 2024 $-0.22 — — — — financials
Sun Mar 31, 2024Mar 2024 $-0.22 — — — — financials
Sat Sep 30, 2023Sep 2023 $-0.24 — — — — financials
Fri Jun 30, 2023Jun 2023 $-0.45 — — — — financials
Fri Mar 31, 2023Mar 2023 $-0.26 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$318,000$215,000—$378,000$593,000$1M—$2M
Cost of revenue————————
Gross profit————————
Operating income$-34M$-31M—$-30M$-31M$-28M—$-29M
Net income$-33M$-30M—$-29M$-31M$-26M—$-27M
EPS (diluted)$-0.21$-0.19—$-0.20$-0.24$-0.21—$-0.24

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$108M$9M$20M$9M$38M$47M$41M$38M
Inventory————————
Total current assets$208M$132M$150M$175M$137M$156M$134M$150M
Total assets$269M$196M$216M$245M$210M$232M$214M$235M
Long-term debt————————
Total liabilities$23M$24M$27M$35M$37M$34M$34M$34M
Total equity$246M$172M$189M$210M$173M$199M$179M$201M

Implied volatility — last 90 days

47%109%172%234%296% Jun 07 — IV 141% · EM ±19.5%Jun 08 — IV 165% · EM ±21.8%Jun 09 — IV 158% · EM ±19.7%Jun 10 — IV 133% · EM ±15.7%Jun 11 — IV 167% · EM ±18.4%Jun 12 — IV 149% · EM ±15.3%Jun 15 — IV 162% · EM ±11.7%Jun 16 — IV 206% · EM ±12.1%Jun 17 — IV 279% · EM ±11.6%Jun 19 — IV 93% · EM ±20.6%Jun 22 — IV 117% · EM ±24.5%Jun 23 — IV 139% · EM ±28.3%Jun 24 — IV 131% · EM ±26.2%Jun 25 — IV 126% · EM ±24.8%Jun 26 — IV 130% · EM ±24.8%Jun 29 — IV 121% · EM ±21.5%Jun 30 — IV 120% · EM ±20.7%Jul 01 — IV 129% · EM ±21.6%Jul 02 — IV 130% · EM ±21.1%Jul 03 — IV 135% · EM ±21.1%Jul 06 — IV 127% · EM ±17.6%Jul 07 — IV 145% · EM ±19.2%Jul 08 — IV 169% · EM ±21.2%Jul 09 — IV 124% · EM ±14.6%Jul 10 — IV 120% · EM ±13.2%Jul 13 — IV 108% · EM ±9.1%Jul 14 — IV 108% · EM ±7.8%Jul 15 — IV 108% · EM ±6.4%Jul 16 — IV 189% · EM ±7.9%Jul 20 — IV 125% · EM ±29.4%Jul 21 — IV 113% · EM ±26.4%Jul 22 — IV 121% · EM ±27.6%Jul 23 — IV 134% · EM ±30.1%Jul 24 — IV 118% · EM ±26.1%Jul 27 — IV 154% · EM ±32.1%Jul 28 — IV 173% · EM ±35.4%Jul 29 — IV 122% · EM ±24.5%Jul 30 — IV 150% · EM ±29.4%Jul 31 — IV 107% · EM ±20.6%Aug 03 — IV 122% · EM ±21.7%Aug 04 — IV 113% · EM ±19.4%Aug 05 — IV 126% · EM ±21.1%Aug 06 — IV 147% · EM ±23.8%Aug 07 — IV 106% · EM ±16.5%Aug 10 — IV 123% · EM ±17.0%Aug 11 — IV 175% · EM ±23.1%Aug 12 — IV 121% · EM ±15.1%Aug 13 — IV 114% · EM ±13.5%Aug 14 — IV 99% · EM ±10.9%Aug 17 — IV 126% · EM ±10.6%Aug 18 — IV 117% · EM ±8.5%Aug 19 — IV 136% · EM ±8.0%Aug 20 — IV 168% · EM ±7.0%Aug 24 — IV 110% · EM ±22.9%Aug 25 — IV 90% · EM ±18.4%Aug 26 — IV 104% · EM ±20.9%Aug 27 — IV 106% · EM ±20.7%Aug 28 — IV 106% · EM ±20.3%Aug 31 — IV 97% · EM ±17.1%Sep 01 — IV 102% · EM ±17.5%Sep 02 — IV 105% · EM ±17.6%Sep 03 — IV 81% · EM ±13.2%Sep 04 — IV 97% · EM ±15.1%Sep 07 — IV 110% · EM ±15.3%Sep 08 — IV 123% · EM ±16.3%Sep 09 — IV 122% · EM ±15.3%Sep 10 — IV 122% · EM ±14.4%Sep 11 — IV 118% · EM ±13.1%Sep 14 — IV 170% · EM ±14.2%Sep 15 — IV 173% · EM ±12.5%Sep 16 — IV 163% · EM ±9.6%Sep 17 — IV 297% · EM ±12.4%Sep 21 — IV 88% · EM ±18.3%Sep 22 — IV 86% · EM ±17.5%Sep 23 — IV 87% · EM ±17.4%Sep 24 — IV 84% · EM ±16.4%Sep 25 — IV 78% · EM ±14.9%Sep 28 — IV 89% · EM ±15.8%Sep 29 — IV 92% · EM ±15.8%Sep 30 — IV 83% · EM ±13.9%Oct 01 — IV 81% · EM ±13.0%Oct 02 — IV 81% · EM ±12.6%Oct 05 — IV 91% · EM ±12.7%Oct 06 — IV 90% · EM ±11.9%Oct 07 — IV 48% · EM ±6.0%Oct 08 — IV 99% · EM ±11.7%Oct 09 — IV 98% · EM ±10.8%

Sector peers

OABI
OmniAb, Inc.
$663M $4.78-3.6%
NRC
NRC Health
$447M $21.38+3.3%
MXCT
MaxCyte, Inc.
$112M $1.430.0%
ONMD
OneMedNet Corp
$33M $4.91+3.4%
NOTV
Inotiv, Inc.
$10M $0.08
BIAF
bioAffinity Technologies, Inc.
$7M $3.17-13.4%

ABSI earnings FAQ

What is ABSI's expected move for earnings?

Options currently price a move of about ±10.8%, or $1.01 per share either way from $9.37.

How does ABSI stock usually react to earnings?

Across the last 2 reports the average next-day move was ±2.2%, up 1 times and down 1 times.

What is ABSI's implied volatility?

ABSI's at-the-money implied volatility is about 98% based on the latest options snapshot.

View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in